Large-scale testing (Phase 3)Study completedNCT00003367What this trial is testingDiet and PSA Levels in Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 154
Testing effectiveness (Phase 2)Looking for participantsNCT05806515What this trial is testingCarboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationWho this might be right forProstate AdenocarcinomaStage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8 SWOG Cancer Research Network 44
Testing effectiveness (Phase 2)Ended earlyNCT04423913What this trial is testingSafety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical ProstatectomyWho this might be right forProstate Cancer Centre Hospitalier Universitaire de Nīmes 12
Testing effectiveness (Phase 2)Study completedNCT02023697What this trial is testingStandard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the BoneWho this might be right forProstatic Neoplasms Bayer 391
Testing effectiveness (Phase 2)WithdrawnNCT06765954What this trial is testingImmunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.Who this might be right forHigh-risk Prostate Cancer ImmunityBio, Inc.
Not applicableStudy completedNCT01542021What this trial is testingAndrogen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancerWho this might be right forProstate CancerProstatic Adenocarcinoma Memorial Sloan Kettering Cancer Center 41
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530What this trial is testingCOACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerWho this might be right forProstate Cancer Brazilian Clinical Research Institute 144
Testing effectiveness (Phase 2)Study completedNCT03643107What this trial is testingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Who this might be right forMetastatic Castration-Resistant Prostate Cancer Patients Allarity Therapeutics 15
Large-scale testing (Phase 3)UnknownNCT00175396What this trial is testingAndrogen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyWho this might be right forProstate Cancer University of British Columbia 400
Large-scale testing (Phase 3)Study completedNCT00002703What this trial is testingRadiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerWho this might be right forProstate Cancer Proton Radiation Oncology Group 390
Not applicableActive Not RecruitingNCT05027477What this trial is testingA Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma Profound Medical Inc. 201
Testing effectiveness (Phase 2)Looking for participantsNCT04700332What this trial is testingPyL in Patients With High Risk and Biochemically Recurrent Prostate CancerWho this might be right forProstate Cancer Hoag Memorial Hospital Presbyterian 184
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07291557What this trial is testingPSMA-PET Directed Radiation Therapy for High-Risk Prostate CancerWho this might be right forProstate Cancer AHS Cancer Control Alberta 250
Large-scale testing (Phase 3)Study completedNCT01546987What this trial is testingHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 239
Testing effectiveness (Phase 2)Looking for participantsNCT07262619What this trial is testingEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsWho this might be right forAdvanced Solid TumorsMSI-H or dMMR Advanced Solid TumorsMSI-H/dMMR Gastric Cancer+4 more Eikon Therapeutics 160
Testing effectiveness (Phase 2)Study completedNCT00596011What this trial is testingStudy of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaWho this might be right forProstatic Hyperplasia H. Lee Moffitt Cancer Center and Research Institute 97
Large-scale testing (Phase 3)Looking for participantsNCT05448547What this trial is testingImmediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerWho this might be right forProstate Cancer Sven Löffeler 980
Not applicableUnknownNCT01913717What this trial is testingShort-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant LesionWho this might be right forAdenocarcinoma of Prostate European Institute of Oncology 65
Not applicableStudy completedNCT00898274What this trial is testingStudy of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsWho this might be right forPrecancerous ConditionProstate Cancer Case Comprehensive Cancer Center 40
Not applicableEnded earlyNCT01488968What this trial is testingConventional Versus Hypofractionated Radiation in High Risk Prostate PatientsWho this might be right forHigh-risk Prostate Cancer AHS Cancer Control Alberta 111